PMID: 6114023May 1, 1981Paper

Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study

Gut
P A Van HeesJ H van Tongeren

Abstract

The response of active Crohn's disease to sulphasalazine (4-6 g per day) has been studied in a placebo-controlled trial. The study was carried out at two hospitals. From August 1977 to August 1979 all patients with established Crohn's disease were examined for their eligibility for the trial. A nine-item index of inflammatory activity was used as the primary measure of response. The variables in this index were serum albumin, ESR, body weight released to height, abdominal mass, temperature, stool consistency, bowel resection, and extraintestinal symptoms related to Crohn's disease. A favourable response to therapy was defined as a decrease of the activity index with 25% or more at the end of the trial period, compared with the initial value. Twenty-six patients (13 in each treatment group) have been followed up for six months. The response of active Crohn's disease to sulphasalazine was significantly better than to placebo.

References

Aug 1, 1975·Gastrointestinal Endoscopy·K Geboes, G Vantrappen
Dec 1, 1972·American Journal of Ophthalmology·J SüvegesB Alberth
Jan 1, 1974·Current Medical Research and Opinion·I K Tsegos, M Y Ekdawi
Apr 1, 1980·Gut·P A van HeesJ H van Tongeren

❮ Previous
Next ❯

Citations

Sep 26, 2008·Inflammatory Bowel Diseases·Kerri NovakRemo Panaccione
Jul 1, 1983·Digestive Diseases and Sciences·R P ChanJ E Lennard-Jones
May 1, 1981·Irish Journal of Medical Science·J F Fielding
Mar 1, 1992·Baillière's Clinical Gastroenterology·R J Polson, J J Misiewicz
Jun 1, 1994·Baillière's Clinical Gastroenterology·S P Travis, D P Jewell
Feb 1, 1996·Pediatric Clinics of North America·B S Kirschner
Feb 24, 2001·The Surgical Clinics of North America·R B Stein, G R Lichtenstein
Jun 18, 1999·Gastroenterology Clinics of North America·R B Stein, S B Hanauer
Dec 9, 1998·Alimentary Pharmacology & Therapeutics·J M Subhani, M I Hamiliton
Nov 1, 2007·Clinics in Colon and Rectal Surgery·Paul A FeldmanJamie S Barkin
Oct 3, 1991·The New England Journal of Medicine·D K Podolsky
Jan 1, 1996·Inflammatory Bowel Diseases·I D DʼagataE Seidman
May 21, 2005·Inflammatory Bowel Diseases·Stephen B Hanauer
Dec 1, 1984·Antimicrobial Agents and Chemotherapy·R J ChiodiniR S Merkal
Feb 2, 2008·Digestion·Pierre MichettiChristian Felley
Nov 26, 2009·World Journal of Gastroenterology : WJG·Tatiana Sofía Rodríguez-ReynaJesús Kazúo Yamamoto-Furusho
Apr 30, 2011·World Journal of Gastroenterology : WJG·Paolo GionchettiFernando Rizzello
Nov 10, 2004·Journal of the American Animal Hospital Association·Albert E Jergens
Mar 10, 2010·Journal of Gastroenterology·Matthias A Engel, Markus F Neurath
Feb 16, 2005·Digestion·Pierre MichettiChristian Felley
Oct 1, 1993·Scandinavian Journal of Gastroenterology·J Brynskov
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·M C RijkJ H van Tongeren
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·S B Hanauer
Jan 1, 2006·Expert Review of Clinical Immunology·Brian W Behm, Stephen J Bickston
Jun 13, 2015·The Journal of Investigative Dermatology. Symposium Proceedings·Fangping YangQinghe Xing
Feb 19, 2009·European Journal of Radiology·Debra J Helper
Jul 6, 2004·Alimentary Pharmacology & Therapeutics·J R Bebb, B B Scott
Aug 5, 2003·Alimentary Pharmacology & Therapeutics·W J Sandborn, B G Feagan
Jul 20, 2007·Alimentary Pharmacology & Therapeutics·P M IrvingP R Gibson
Aug 1, 1982·British Journal of Clinical Pharmacology·H J Hodgson
Apr 1, 1987·Journal of Clinical Pharmacology·M A Peppercorn
Jan 19, 1999·Rheumatic Diseases Clinics of North America·F De KeyserE M Veys
Sep 1, 1996·Primary Care·B R Stotland, G R Lichtenstein
Mar 6, 2012·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Byong Duk YeUNKNOWN IBD Study Group of the Korean Association for the Study of the Intestinal Diseases
Mar 1, 1987·The American Journal of Medicine·R I Horwitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.